39 related articles for article (PubMed ID: 31813882)
1. Multiple metabolite profiles uncover remarkable bioactive compounds and metabolic characteristics of noni fruit (Morinda citrifolia L.) at various stages of ripeness.
Su C; Yang M; Chen S; Fu C; Zhang L; Liu S; Kang J; Li C
Food Chem; 2024 Aug; 450():139357. PubMed ID: 38631202
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle arrest and mechanism of apoptosis induction in H400 oral cancer cells in response to Damnacanthal and Nordamnacanthal isolated from Morinda citrifolia.
Shaghayegh G; Alabsi AM; Ali-Saeed R; Ali AM; Vincent-Chong VK; Zain RB
Cytotechnology; 2016 Oct; 68(5):1999-2013. PubMed ID: 27488882
[TBL] [Abstract][Full Text] [Related]
3. Glabraquinone A and B, new
Primus PS; Wu CH; Kao CL; Choo YM
Nat Prod Res; 2024 Apr; 38(8):1406-1413. PubMed ID: 36416441
[TBL] [Abstract][Full Text] [Related]
4. Combination of Nanodelivery Systems and Constituents Derived from Novel Foods: A Comprehensive Review.
Truzzi E; Bertelli D; Bilia AR; Vanti G; Maretti E; Leo E
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004592
[TBL] [Abstract][Full Text] [Related]
5. The Effects of
Min SK; Oh J; Park JB
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32764294
[No Abstract] [Full Text] [Related]
6. Anticancer and chemopreventive potential of Morinda citrifolia L. bioactive compounds: A comprehensive update.
Kitic D; Miladinovic B; Randjelovic M; Szopa A; Seidel V; Prasher P; Sharma M; Fatima R; Arslan Ateşşahin D; Calina D; Sharifi-Rad J
Phytother Res; 2024 Apr; 38(4):1932-1950. PubMed ID: 38358681
[TBL] [Abstract][Full Text] [Related]
7. Damnacanthal: a promising compound as a medicinal anthraquinone.
Abu N; Ali NM; Ho WY; Yeap SK; Aziz MY; Alitheen NB
Anticancer Agents Med Chem; 2014 Jun; 14(5):750-5. PubMed ID: 24164045
[TBL] [Abstract][Full Text] [Related]
8. The antinociceptive and anti-inflammatory action of the CHCl3-soluble phase and its main active component, damnacanthal, isolated from the root of Morinda citrifolia.
Okusada K; Nakamoto K; Nishida M; Fujita-Hamabe W; Kamiya K; Mizushina Y; Satake T; Tokuyama S
Biol Pharm Bull; 2011; 34(1):103-7. PubMed ID: 21212526
[TBL] [Abstract][Full Text] [Related]
9. Damnacanthal-induced anti-inflammation is associated with inhibition of NF-κB activity.
Nualsanit T; Rojanapanthu P; Gritsanapan W; Kwankitpraniti T; Min KW; Baek SJ
Inflamm Allergy Drug Targets; 2011 Dec; 10(6):455-63. PubMed ID: 21999179
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Effects of Extracts from the Fruit of Morinda Citrifolia (Noni) in Breast Cancer Cell Lines.
Sharma K; Pachauri SD; Khandelwal K; Ahmad H; Arya A; Biala P; Agrawal S; Pandey RR; Srivastava A; Srivastav A; Saxena JK; Dwivedi AK
Drug Res (Stuttg); 2016 Mar; 66(3):141-7. PubMed ID: 26158795
[TBL] [Abstract][Full Text] [Related]
11. Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells.
Nualsanit T; Rojanapanthu P; Gritsanapan W; Lee SH; Lawson D; Baek SJ
J Nutr Biochem; 2012 Aug; 23(8):915-23. PubMed ID: 21852088
[TBL] [Abstract][Full Text] [Related]
12. Development of biodegradable sustained-release damnacanthal nanocapsules for potential application in in-vitro breast cancer studies.
Mohd MR; Ariff TM; Mohamad N; Abdul Latif AZ; Wan Nik WMN; Mohamed A; Suffian IFM
Pak J Pharm Sci; 2019 Sep; 32(5):2155-2162. PubMed ID: 31813882
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
